Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:05:08.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study completion date for the phase II clinical trial of pembrolizumab in patients with relapsed or metastatic osteosarcoma not eligible for curative surgery.
    Difference
    0.1%
    Check dated 2024-06-06T14:18:26.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to provide a detailed description of eligibility criteria, including examples such as a person's general health condition or prior treatments. The new text also directs users to 'Learn About Studies' for general information about clinical research.
    Difference
    45%
    Check dated 2024-05-22T20:56:12.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:56:14.000Z thumbnail image

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.